Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio
Acquisition focused on clinical-stage program potravitug, a first-in-class BK polyomavirus [...]
Santhera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE®
Data support AGAMREE®’s potential use as a treatment across a [...]
Eurobio Scientific finalizes the acquisition of CareDX’s transplant Lab Product division
Acceleration of Eurobio’s strategic plan to become an in-vitro molecular [...]
Nectero Therapeutics Presents Two-Year Proximal Neck Dynamics From First-in-Human Study of Abdominal Aortic Aneurysm Treatment
Data Presented on Two-Year Proximal Neck Dynamics From First-in-Human Study [...]
Welbeck Health Partners Adopts OMED Health’s Home-Based SIBO Testing Pathway Across Its Network
Patients complete SIBO breath testing at home, with diagnosis provided [...]
Jonathan J Mazelsky Appointed to the BOD of Insulet Corporation
Jay Mazelsky: “Insulet has built a strong category-leading business based [...]
Aidoc Receives FDA Breakthrough Device Designation for AI That Drafts Radiology Reports
First Read is designed to help radiologists meet rising imaging [...]
Celerion Expands Zurich Bioanalytical Laboratory to Meet Growing Market Demand
The investment strengthens Celerion’s ability to support increasing global demand [...]
The Quiet Infrastructure Behind Every Hospital Room: What Wholesale Medical Supplies Actually Cover
A facility that treats its supply chain as a strategic [...]
HKeyBio Launches NHP Fast-Tox Program for Accelerating Non-GLP NHP Safety Risk Screening
The program supports early tolerability assessment, PK/TK-linked safety evaluation, immune-related [...]